Table 2 Dichotomous outcomes
Outcome | Placebo (n = 40) | NAC + DFX (n = 40) | Relative risk, non-adjusted (95 % CI) | Relative risk, adjusted (95 % CI) |
|---|---|---|---|---|
AKI incidence | 27 (67) | 26 (65) | 0.89 (0.35–2.2) | 1.1 (0.37–3.2) |
AKI severity, stages 2 and 3, n (%) | 24 (60) | 15 (37) | 0.4 (0.16–0.98) | 0.35 (0.13–0.93) |
RRT, n (%) | 6 (15) | 6 (15) | 1.0 (0.29–3.4) | 1.1 (0.3–4.2) |
ICU death, n (%) | 21 (52) | 23 (57) | 1.22 (0.50–2.9) | 1.6 (0.58–4.4) |
Hospital death, n (%) | 23 (57) | 24 (60) | 1.1 (0.45–2.7) | 1.3 (0.51–3.7) |